PS
Piper Sandler Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
1326 |
1326
Renasant Corp
RNST
$3.75B
| $39.48 | $28 |
29%
downside
| Neutral | 4 years ago |
|
|
1327 |
1327
Peapack-Gladstone Financial
PGC
$510M
| $28.90 | $24 |
17%
downside
| Overweight | 4 years ago |
|
|
1328 |
1328
Merit Medical Systems
MMSI
$5.51B
|
MO
Matt OBrien
| $92.97 | $62 |
33%
downside
| Overweight | 4 years ago |
|
1329 |
1329
Integra LifeSciences
IART
$1.25B
|
MO
Matthew O'Brien
| $15.99 | $47 |
194%
upside
| Neutral | 4 years ago |
|
1330 |
1330
Gilead Sciences
GILD
$143B
|
TVB
Tyler Van Buren
| $115.05 | $84 |
27%
downside
| Overweight | 4 years ago |
|
1331 |
1331
First Interstate BancSystem
FIBK
$3.41B
| $32.55 | $40 |
23%
upside
| Overweight | 4 years ago |
|
|
1332 |
1332
Capitol Federal Financial
CFFN
$846M
| $6.49 | $12 |
85%
upside
| Neutral | 4 years ago |
|
|
1333 |
1333
Popular Inc
BPOP
$8.47B
| $125.34 | $62 |
51%
downside
| Overweight | 4 years ago |
|
|
1334 |
1334
Moelis & Co
MC
$5.24B
|
JH
Jeff Harte
| $70.68 | $41 |
42%
downside
| Neutral | 4 years ago |
|
1335 |
1335
HCA Healthcare
HCA
$98.5B
|
SJ
Sarah James
| $420.77 | $149 |
65%
downside
| Neutral | 4 years ago |
|
1336 |
1336
HBT Financial
HBT
$828M
| $26.30 | $14 |
47%
downside
| Neutral | 4 years ago |
|
|
1337 |
1337
1st Source
SRCE
$1.57B
| $64.16 | $44 |
31%
downside
| Overweight | 4 years ago |
|
|
1338 |
1338
First Financial Bankshares
FFIN
$5.22B
|
BM
Brad Milsaps
| $36.73 | $28 |
24%
downside
| Underweight | 4 years ago |
|
1339 |
1339
Esquire Financial Holdings
ESQ
$828M
|
NC
Nicholas Cucharale
| $97.01 | $20 |
79%
downside
| Overweight | 4 years ago |
|
1340 |
1340
Civista Bancshares
CIVB
$406M
|
NC
Nicholas Cucharale
| $21.02 | $17.50 |
17%
downside
| Overweight | 4 years ago |
|
1341 |
1341
Guaranty Bancshares
GNTY
$562M
|
BM
Brad Milsaps
| $49.54 | $29.09 |
41%
downside
| Neutral | 4 years ago |
|
1342 |
1342
Agios Pharmaceuticals
AGIO
$2.09B
| $36.01 | $73 |
103%
upside
| Overweight | 4 years ago |
|
|
1343 |
1343
Edwards Lifesciences
EW
$47.5B
|
WQ
William Quirk
| $80.94 | $93 |
15%
upside
| Overweight | 4 years ago |
|
1344 |
1344
Targa Resources
TRGP
$34.9B
| $162.35 | $19 |
88%
downside
| Neutral | 4 years ago |
|
|
1345 |
1345
Kinder Morgan
KMI
$59.1B
|
PH
Pearce Hammond
| $26.59 | $14 |
47%
downside
| Neutral | 4 years ago |
|
1346 |
1346
Hercules Capital
HTGC
$3.49B
|
AJD
Aaron James Deer
| $19.23 | $13 |
32%
downside
| Overweight | 4 years ago |
|
1347 |
1347
Enterprise Products Partners
EPD
$68.6B
|
PH
Pearce Hammond
| $31.67 | $19 |
40%
downside
| Overweight | 4 years ago |
|
1348 |
1348
Amneal Pharmaceuticals
AMRX
$3.02B
| $9.62 | $6 |
38%
downside
| Overweight | 4 years ago |
|
|
1349 |
1349
Tenaris
TS
$18.2B
|
IM
Ian Macpherson
| $34.88 | $13.50 |
61%
downside
| Neutral | 4 years ago |
|
1350 |
1350
WaFd
WAFD
$2.5B
| $31.75 | $22 |
31%
downside
| Neutral | 5 years ago |
|